NO20040158L - Fremgangsmåte til å amplifisere et Chordopoxvirus. - Google Patents

Fremgangsmåte til å amplifisere et Chordopoxvirus.

Info

Publication number
NO20040158L
NO20040158L NO20040158A NO20040158A NO20040158L NO 20040158 L NO20040158 L NO 20040158L NO 20040158 A NO20040158 A NO 20040158A NO 20040158 A NO20040158 A NO 20040158A NO 20040158 L NO20040158 L NO 20040158L
Authority
NO
Norway
Prior art keywords
amplifying
chordopox virus
chordopox
virus
Prior art date
Application number
NO20040158A
Other languages
English (en)
Other versions
NO339056B1 (no
Inventor
Paul Howley
Karl Heller
Ingmar Räthe
Original Assignee
Bavarian Nordic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20040158(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bavarian Nordic As filed Critical Bavarian Nordic As
Publication of NO20040158L publication Critical patent/NO20040158L/no
Publication of NO339056B1 publication Critical patent/NO339056B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/065—Poxviridae, e.g. avipoxvirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/065—Poxviridae, e.g. avipoxvirus
    • C07K14/07—Vaccinia virus; Variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
NO20040158A 2001-07-18 2004-01-13 Fremgangsmåte til å amplifisere et Chordopoxvirus. NO339056B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101122 2001-07-18
PCT/EP2002/007280 WO2003008533A2 (en) 2001-07-18 2002-07-02 Method for virus propagation

Publications (2)

Publication Number Publication Date
NO20040158L true NO20040158L (no) 2004-01-13
NO339056B1 NO339056B1 (no) 2016-11-07

Family

ID=8160630

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040158A NO339056B1 (no) 2001-07-18 2004-01-13 Fremgangsmåte til å amplifisere et Chordopoxvirus.

Country Status (19)

Country Link
US (1) US6924137B2 (no)
EP (1) EP1412486B1 (no)
JP (2) JP4700907B2 (no)
KR (1) KR100908377B1 (no)
CN (1) CN100513560C (no)
AU (1) AU2002314201B2 (no)
BR (2) BRPI0211276B1 (no)
CA (1) CA2450206C (no)
DE (1) DE60223812T2 (no)
DK (1) DK1412486T3 (no)
EA (1) EA006628B1 (no)
HU (1) HUP0400393A3 (no)
IL (2) IL158927A0 (no)
MX (1) MXPA04000326A (no)
NO (1) NO339056B1 (no)
NZ (1) NZ529914A (no)
PL (1) PL205926B1 (no)
UA (1) UA82466C2 (no)
WO (1) WO2003008533A2 (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO343489B1 (no) * 2002-09-05 2019-03-25 Bavarian Nordic As Fremgangsmåte til amplifisering av en poxvirus under serumfrie betingelser.

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
HU230198B1 (hu) * 2000-11-23 2015-10-28 Bavarian Nordic A/S Módosított Vacciniavírus Ankara-variáns
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
WO2014009433A1 (en) 2012-07-10 2014-01-16 Transgene Sa Mycobacterium resuscitation promoting factor for use as adjuvant
SG11201500171YA (en) 2012-07-10 2015-02-27 Transgene Sa Mycobacterial antigen vaccine
EP3092000A1 (en) 2014-01-09 2016-11-16 Transgene SA Fusion of heterooligomeric mycobacterial antigens
CA2975432A1 (en) 2015-02-13 2016-08-18 Transgene Sa Immunotherapeutic vaccine and antibody combination therapy
WO2016131945A1 (en) 2015-02-20 2016-08-25 Transgene Sa Combination product with autophagy modulator
FR3042121A1 (fr) 2015-10-08 2017-04-14 Jean-Marc Limacher Composition anti-tumorale
CA3023022A1 (en) 2016-05-04 2017-11-09 Transgene Sa Combination therapy with cpg tlr9 ligand
US10913063B2 (en) * 2016-07-12 2021-02-09 EMULATE, Inc. Removing bubbles in a microfluidic device
WO2018069316A2 (en) 2016-10-10 2018-04-19 Transgene Sa Immunotherapeutic product and mdsc modulator combination therapy
KR20240113607A (ko) 2017-06-21 2024-07-22 트랜스진 개인 맞춤형 백신
EP3842065A1 (en) 2019-12-23 2021-06-30 Transgene Process for designing a recombinant poxvirus for a therapeutic vaccine
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
CN121443308A (zh) 2023-03-17 2026-01-30 亥姆霍兹慕尼黑中心-德国健康与环境研究中心(有限公司) 用于治疗乙型肝炎的hbv抗原制剂
WO2025172435A1 (en) 2024-02-13 2025-08-21 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Hbv antigen formulation for treating hepatitis b
FR3160186A1 (fr) 2024-03-13 2025-09-19 Odimma Therapeutics Vecteur non-viral pour transcription augmentee
WO2026041811A1 (en) 2024-08-23 2026-02-26 Transgene Recombinant poxvirus and method for regulating the expression of toxic conditional gene products of said recombinant poxvirus in a producing cell
FR3171450A1 (fr) 2025-01-17 2026-07-24 Odimma Therapeutics Virus enveloppé pour la transfection d’acides nucléiques exogènes.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2384845A1 (fr) * 1976-08-05 1978-10-20 Anvar Vaccin contre la myxomatose et nouvelle souche virale utilisee
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US5616487A (en) * 1994-09-15 1997-04-01 Aastrom Biosciences, Inc. Stabilized retrovirus compositions
US6264957B1 (en) * 1995-09-27 2001-07-24 The United States Of America As Represented By The Department Of Health And Human Services Product of infectious respiratory syncytial virus from cloned nucleotide sequences
EP0912724B1 (en) * 1996-07-15 2009-12-09 The Government of The United States of America, as represented by The Department of Health and Human Services Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
HU230198B1 (hu) * 2000-11-23 2015-10-28 Bavarian Nordic A/S Módosított Vacciniavírus Ankara-variáns

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO343489B1 (no) * 2002-09-05 2019-03-25 Bavarian Nordic As Fremgangsmåte til amplifisering av en poxvirus under serumfrie betingelser.

Also Published As

Publication number Publication date
DE60223812D1 (de) 2008-01-10
EA006628B1 (ru) 2006-02-24
JP2011078424A (ja) 2011-04-21
AU2002314201B2 (en) 2006-09-21
BR0211276A (pt) 2004-08-03
DK1412486T3 (da) 2008-03-10
MXPA04000326A (es) 2005-03-07
EP1412486A2 (en) 2004-04-28
CN1533433A (zh) 2004-09-29
KR100908377B1 (ko) 2009-07-20
US20040234950A1 (en) 2004-11-25
PL366897A1 (en) 2005-02-07
HK1066245A1 (zh) 2005-03-18
HUP0400393A3 (en) 2004-10-28
NZ529914A (en) 2005-03-24
BRPI0211276B1 (pt) 2018-12-04
JP5154632B2 (ja) 2013-02-27
WO2003008533A2 (en) 2003-01-30
WO2003008533A3 (en) 2004-01-08
IL158927A0 (en) 2004-05-12
UA82466C2 (uk) 2008-04-25
JP2004535203A (ja) 2004-11-25
CA2450206A1 (en) 2003-01-30
IL158927A (en) 2009-09-01
CA2450206C (en) 2012-08-21
JP4700907B2 (ja) 2011-06-15
NO339056B1 (no) 2016-11-07
DE60223812T2 (de) 2008-11-13
US6924137B2 (en) 2005-08-02
KR20040018474A (ko) 2004-03-03
PL205926B1 (pl) 2010-06-30
EA200400195A1 (ru) 2004-06-24
HUP0400393A2 (hu) 2004-07-28
EP1412486B1 (en) 2007-11-28
CN100513560C (zh) 2009-07-15

Similar Documents

Publication Publication Date Title
DE60221745D1 (de) Operationelle Verstärkerschaltung, Treiberschaltung und -Verfahren
DE60218781D1 (de) Operationelle Verstärkerschaltung, Treiberschaltung und -Verfahren
NO20040654L (no) Gassmikrosfaere-liposomkompositter.
ATE502118T1 (de) Amplifizierungsverfahren
DK1412486T3 (da) Fremgangsmåde til virusformering
NO20040387L (no) Nedihullsfrigjoringskopling.
DE60201856D1 (de) Klasse-D Verstärker
DE60236621D1 (de) Smedium
DE60222443D1 (de) Vorverstärkungsschaltung
DZ3441A1 (fr) Nouvelles phenylpiperazines.
NO20040549L (no) Komplettering av laterale bronnboringer.
DE60226093D1 (de) Urmedium-Reinigungsmethode
DE60225412D1 (de) Wanderfeldröhre
ITMI20022425A1 (it) Distanziatore e distanziale.
ES1048400Y (es) Bota-patin mejorada.
NL1021007A1 (nl) Beugelslot.
BR0103827B1 (pt) cola - pds.
PT1179650E (pt) Palco aperfeicoado
ES1049946Y (es) Caja-trampa antiorugas.
ES1050491Y (es) Chupete infantil.
BR8101236Y1 (pt) desensiladeira.
NO20040693L (no) Fermenteringsmetode.
ES1048703Y (es) Conversor.
ES1050980Y (es) Portalamparas.
ES1048140Y (es) Calcetin-zapato.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees